Experience in using specific recombinant monoclonal antibodies in comorbid patients with coronavirus infection
Introduction: against the background of the ongoing incidence of coronavirus infection, the selection of therapy often requires individual approaches, especially in comorbid patients. Despite the emergence of specific prevention methods and new antiviral drugs, there are risk groups for severe disea...
Saved in:
| Main Authors: | S. A. Sokotun, A. I. Simakova, A. O. Mikhailov, N. G. Plekhova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2024-12-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1710 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies against Coronavirus SARS-CоV-2
by: G. V. Kuklina, et al.
Published: (2023-05-01) -
Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01) -
Monoclonal Antibodies for COVID-19 Treatment: Is It an Option in Indonesia?
by: Alvina Widhani
Published: (2023-11-01) -
The Research Progress of Monoclonal Antibody Labeled with 89Zr
by: Zhanxiong XIAO, et al.
Published: (2025-04-01) -
Development and characterization of monoclonal antibodies specific for bovine IP-10
by: Hamza Khalid, et al.
Published: (2025-08-01)